Thromboembolism of the Graft

Drug	Drug Name	Drug Description
DB00013	Urokinase	A low molecular weight form of human urokinase used to treat pulmonary embolism and myocardial infarction as well as to clear IV lines.

Drug	Drug Name	Target	Type
DB00013	Urokinase	Urokinase plasminogen activator surface receptor	target
DB00013	Urokinase	Plasminogen	target
DB00013	Urokinase	Plasminogen activator inhibitor 2	target
DB00013	Urokinase	Plasminogen activator inhibitor 1	target
DB00013	Urokinase	Plasma serine protease inhibitor	target
DB00013	Urokinase	Nidogen-1	target
DB00013	Urokinase	Low-density lipoprotein receptor-related protein 2	target
DB00013	Urokinase	Suppressor of tumorigenicity 14 protein	target
DB00013	Urokinase	Macrophage metalloelastase	enzyme

Drug	Drug Name	Phase	Status	Count